7E3K

Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants

7E3K の概要

• エントリーDOI: 10.2210/pdb7e3k/pdb
• EMDBエントリー: 30982 30983
• 分子名称: Spike glycoprotein, 13G9 heavy chain, 13G9 light chain, ... (4 entities in total)
• 機能のキーワード: covid-19, spike glycoprotein, virus, viral protein, antibody
• 由来する生物種: Severe acute respiratory syndrome coronavirus 2 (2019-nCoV); 詳細
• タンパク質・核酸の鎖数: 9
• 化学式量合計: 573276.21

構造登録者

Guo, H.,Li, T.,Liu, F.,Gao, Y.,Ji, X.,Yang, H. (登録日: 2021-02-09, 公開日: 2021-09-15, 最終更新日: 2022-03-02)

• 主引用文献: Li, T.,Han, X.,Gu, C.,Guo, H.,Zhang, H.,Wang, Y.,Hu, C.,Wang, K.,Liu, F.,Luo, F.,Zhang, Y.,Hu, J.,Wang, W.,Li, S.,Hao, Y.,Shen, M.,Huang, J.,Long, Y.,Song, S.,Wu, R.,Mu, S.,Chen, Q.,Gao, F.,Wang, J.,Long, S.,Li, L.,Wu, Y.,Gao, Y.,Xu, W.,Cai, X.,Qu, D.,Zhang, Z.,Zhang, H.,Li, N.,Gao, Q.,Zhang, G.,He, C.,Wang, W.,Ji, X.,Tang, N.,Yuan, Z.,Xie, Y.,Yang, H.,Zhang, B.,Huang, A.,Jin, A.; Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants.; Nat Commun, 12:6304-6304, 2021; PubMed: 34728625; DOI: 10.1038/s41467-021-26539-7

実験手法

ELECTRON MICROSCOPY (3.9 Å)